Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Choosing the right credit card for travel rewards can be challenging. Find out which options provide the best benefits for you.
27,921 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
As market conditions shift in 2026, many 401(K) accounts look solid on paper but lag in real terms. This report highl...
Washington moves to outlaw noncompete agreements statewide, imposing a 2027 deadline. The sweeping policy reshapes hi...
United Wholesale Mortgage reports a profitable first quarter as originations slow. CEO Mat Ishbia escalates pressure ...
OpenPayd’s Chief Commercial Officer explains how a unified financial infrastructure and growing stablecoins are accel...
Technology firms are slashing thousands of roles as AI adoption accelerates. Coinbase, Cloudflare, and Upwork lead a ...
A drone strike lit a cargo ship off Qatar, testing a fragile Iran ceasefire. UAE and Kuwait reported drone incursions...
When a punchline hits a nerve, the money side of fame can swing just as hard. This article breaks down how pete david...
A new Goldman Sachs study argues physical infrastructure and skilled labor will cap AI expansion even as demand for a...
Markets question whether Kevin Warsh can deliver the rate cuts President Trump wants, signaling that wall street long...
In a chaotic but decisive session, the CLARITY Act survived chaotic senate moves and cleared the Senate Banking Commi...
Retirees face rising tax headwinds as withdrawals, Social Security, and Medicare premiums stack. A shift to proactive...